SCHEMBL257487

SCHEMBL257487

CCc1cc(C(=O)c2nccn2C)ccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.51
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 3/20 0.47
LMNA P02545 3/20 0.47
GAA P10253 2/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
LDHA P00338 8/20 0.42
LDHB P07195 8/20 0.42
TSHR P16473 2/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
THRB P10828 1/20 0.39
PABPC1 P11940 1/20 0.39
HPGD P15428 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15197113 0.81 HTT (0.53) HTTKMT2AALDH1A1LMNAGAA
SCHEMBL15197114 0.76 SMN1; SMN2 (0.58) HTTKMT2AALDH1A1LMNAGAA
SCHEMBL277909 0.74 ALDH1A1 (0.54) HTTKMT2AALDH1A1GAAMAPT
SCHEMBL1045991 0.74 SMN1; SMN2 (0.58) HTTKMT2AALDH1A1LMNAGAA
SCHEMBL6563493 0.71 HTT (0.49) HTTKMT2AALDH1A1LMNAGAA
SCHEMBL5918187 0.71 LDHA (0.60) HTTKMT2AALDH1A1LMNAGAA
SCHEMBL6920434 0.71 MAPT (0.54) HTTKMT2AALDH1A1LMNAGAA
SCHEMBL5604635 0.71 TSHR (0.49) HTTKMT2AALDH1A1LMNAGAA
SCHEMBL16632153 0.71 SMN1; SMN2 (0.52) HTTKMT2AALDH1A1LMNAGAA
SCHEMBL2000489 0.70 RXRA (0.44) KMT2AALDH1A1TSHRRAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 HTT 3281/4885KMT2A 1199/4885ALDH1A1 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.